During the past decade, Toyama University Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toyama University Hospital" #1 sponsor was "Bayer" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "Janssen Pharmaceutical K.K." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toyama University Hospital" #1 collaborator was "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Alpha-A, Inc." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Toyama University Hospital" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Gastrointestinal Stromal Tumor" (2 trials), "Metastatic Cancer" (2 trials) and "Urinary Bladder Neoplasms" (2 trials). Many other conditions were trialed in "Toyama University Hospital" in a lesser frequency.

Most popular intervention types in "Toyama University Hospital" are "Drug" (24 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Avelumab" (2 trials), "Cisplatin" (2 trials), "Docetaxel" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Toyama University Hospital" are 26 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Toyama University Hospital". 1 are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Toyama University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Toyama University Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".